Interleukin-1beta suppresses epithelial sodium channel beta-subunit expression and ENaC-dependent fluid absorption in human middle ear epithelial cells.
Recent reports have shown that cytokines inhibit fluid absorption by suppressing Na(+) channel activity in various epithelia. In this study, we investigated the role of epithelial sodium channel (ENaC) in fluid absorption in normal human middle ear epithelial (NHMEE) cells, as well as the effects of Interleukin (IL)-1beta on ENaC expression and fluid absorption in NHMEE cells. We confirmed that ENaC alpha, beta and gamma were predominantly expressed on the apical surface of the NHMEE cells by immunocytochemistry. Addition of amiloride, a potent ENaC blocker, to apical membranes of NHMEE cells decreased the fluid absorption rate in a dose-dependent manner. Treatment with 10 ng/ml IL-1beta for 24 h suppressed ENaC beta expression, the ENaC-dependent short-circuit current (Isc), and ENaC-dependent fluid absorption. When the NHMEE cells were pretreated with a phospholipase C (PLC)inhibitor (U73122, 10 microM), a protein kinase C (PKC) inhibitor (Calphostin C, 0.1 microM), or extracellular signal regulated kinase (ERK) 1/2 inhibitor (PD98059, 10 microM), the amiloride-sensitive currents in IL-1beta-treated cells were reversed to control levels; an effect not seen with SB202190 (an inhibitor of p38 mitogen-activated protein (MAP) kinase) or SP600125 (a reversible inhibitor of c-Jun N-terminal kinase). In this study we showed that ENaC is essential for fluid absorption in NHMEE cells and that IL-1beta suppresses the ENaC-dependent current via the PLC-PKC-ERK1/2 pathway. These results suggest that IL-1beta may contribute to fluid retention in otitis media with effusion by changing electrolyte transport and reducing middle ear epithelial fluid absorption.
Choi
Jae Young
JY
Department of Otorhinolaryngology, Yonsei University College of Medicine, Seoul, Republic of Korea.
Choi
Yoon-Seok
YS
Kim
Su Jin
SJ
Son
Eun Jin
EJ
Choi
Hyun Seung
HS
Yoon
Joo-Heon
JH
D000042:Absorption; D001639:Bicarbonates; D002021:Buffers; D002460:Cell Line; D004432:Ear, Middle / Q000166:cytology / Q000378:metabolism*; D004847:Epithelial Cells / Q000166:cytology / Q000378:metabolism*; D053503:Epithelial Sodium Channels / Q000096:biosynthesis*; D006801:Humans; D007150:Immunohistochemistry; D053583:Interleukin-1beta / Q000494:pharmacology / Q000502:physiology*; D020033:Protein Isoforms / Q000096:biosynthesis; D015398:Signal Transduction; D026941:Sodium Channel Blockers / Q000494:pharmacology; D012996:Solutions; D014867:Water / Q000378:metabolism*
D001639:Bicarbonates; D002021:Buffers; D053503:Epithelial Sodium Channels; D053583:Interleukin-1beta; D020033:Protein Isoforms; D026941:Sodium Channel Blockers; D012996:Solutions; D014867:Water